224 related articles for article (PubMed ID: 26773343)
1. Exposure to chlorpyrifos increases neutral lipid accumulation with accompanying increased de novo lipogenesis and decreased triglyceride secretion in McArdle-RH7777 hepatoma cells.
Howell GE; Mulligan C; Young D; Kondakala S
Toxicol In Vitro; 2016 Apr; 32():181-9. PubMed ID: 26773343
[TBL] [Abstract][Full Text] [Related]
2. "Trans-nonachlor increases extracellular free fatty acid accumulation and de novo lipogenesis to produce hepatic steatosis in McArdle-RH7777 cells".
Howell GE; McDevitt E; Henein L; Mulligan C; Young D
Toxicol In Vitro; 2018 Aug; 50():285-292. PubMed ID: 29654899
[TBL] [Abstract][Full Text] [Related]
3. Alterations in cellular lipid metabolism produce neutral lipid accumulation following exposure to the organochlorine compound trans-nonachlor in rat primary hepatocytes.
Howell GE; McDevitt E; Henein L; Mulligan C; Young D
Environ Toxicol; 2018 Sep; 33(9):962-971. PubMed ID: 29964320
[TBL] [Abstract][Full Text] [Related]
4. In Vitro effect of DDE exposure on the regulation of lipid metabolism and secretion in McA-RH7777 hepatocytes: A potential role in dyslipidemia which may increase the risk of type 2 diabetes mellitus.
Ward AB; Dail MB; Chambers JE
Toxicol In Vitro; 2016 Dec; 37():9-14. PubMed ID: 27565303
[TBL] [Abstract][Full Text] [Related]
5. Effects of chlorpyrifos on non-cholinergic toxicity endpoints in immortalized and primary rat hepatocytes under normal and hepatosteatotic conditions.
Kondakala S; Henein L; McDevitt E; Ross MK; Howell GE
Toxicol In Vitro; 2022 Apr; 80():105329. PubMed ID: 35151815
[TBL] [Abstract][Full Text] [Related]
6. Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells.
Anthérieu S; Rogue A; Fromenty B; Guillouzo A; Robin MA
Hepatology; 2011 Jun; 53(6):1895-905. PubMed ID: 21391224
[TBL] [Abstract][Full Text] [Related]
7. Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.
Cedó L; Santos D; Roglans N; Julve J; Pallarès V; Rivas-Urbina A; Llorente-Cortes V; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
PLoS One; 2017; 12(12):e0189834. PubMed ID: 29244870
[TBL] [Abstract][Full Text] [Related]
8. Orotic acid-treated hepatocellular carcinoma cells resist steatosis by modification of fatty acid metabolism.
Matilainen J; Mustonen AM; Rilla K; Käkelä R; Sihvo SP; Nieminen P
Lipids Health Dis; 2020 Apr; 19(1):70. PubMed ID: 32284043
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute exposure to chlorpyrifos on cholinergic and non-cholinergic targets in normal and high-fat fed male C57BL/6J mice.
Kondakala S; Lee JH; Ross MK; Howell GE
Toxicol Appl Pharmacol; 2017 Dec; 337():67-75. PubMed ID: 29097212
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cholinergic and non-cholinergic targets following subacute exposure to chlorpyrifos in normal and high fat fed male C57BL/6J mice.
Howell GE; Kondakala S; Holdridge J; Lee JH; Ross MK
Food Chem Toxicol; 2018 Aug; 118():821-829. PubMed ID: 29935250
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of hepatic steatosis in the parenterally fed rat.
Hall RI; Grant JP; Ross LH; Coleman RA; Bozovic MG; Quarfordt SH
J Clin Invest; 1984 Nov; 74(5):1658-68. PubMed ID: 6438155
[TBL] [Abstract][Full Text] [Related]
12. An ANGPTL4-ceramide-protein kinase Cζ axis mediates chronic glucocorticoid exposure-induced hepatic steatosis and hypertriglyceridemia in mice.
Chen TC; Lee RA; Tsai SL; Kanamaluru D; Gray NE; Yiv N; Cheang RT; Tan JH; Lee JY; Fitch MD; Hellerstein MK; Wang JC
J Biol Chem; 2019 Jun; 294(23):9213-9224. PubMed ID: 31053639
[TBL] [Abstract][Full Text] [Related]
13. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
[TBL] [Abstract][Full Text] [Related]
14. Curcumin decreases oleic acid-induced lipid accumulation via AMPK phosphorylation in hepatocarcinoma cells.
Kang OH; Kim SB; Seo YS; Joung DK; Mun SH; Choi JG; Lee YM; Kang DG; Lee HS; Kwon DY
Eur Rev Med Pharmacol Sci; 2013 Oct; 17(19):2578-86. PubMed ID: 24142602
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease.
Kawano Y; Cohen DE
J Gastroenterol; 2013 Apr; 48(4):434-41. PubMed ID: 23397118
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of exendin-4-induced steatosis by protein kinase A in cultured HepG2 human hepatoma cells.
Chen-Liaw AY; Hammel G; Gomez G
In Vitro Cell Dev Biol Anim; 2017 Sep; 53(8):721-727. PubMed ID: 28707223
[TBL] [Abstract][Full Text] [Related]
17. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).
Musso G; Gambino R; Cassader M
Prog Lipid Res; 2009 Jan; 48(1):1-26. PubMed ID: 18824034
[TBL] [Abstract][Full Text] [Related]
18. Modulation of hepatic steatosis by dietary fatty acids.
Ferramosca A; Zara V
World J Gastroenterol; 2014 Feb; 20(7):1746-55. PubMed ID: 24587652
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
Yin Y; Yu Z; Xia M; Luo X; Lu X; Ling W
Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216
[TBL] [Abstract][Full Text] [Related]
20. Development of an in vitro model to study hepatitis C virus effects on hepatocellular lipotoxicity and lipid metabolism.
Koletzko L; Mahli A; Hellerbrand C
Pathol Res Pract; 2018 Oct; 214(10):1700-1706. PubMed ID: 30201523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
